Dissecting the impact of chemotherapy on the human hair follicle: A pragmatic in vitro assay for studying the pathogenesis and potential management of hair follicle dystrophy

American Journal of Pathology

Volumn 171, Issue 4, 2007, Pages 1153-1167

  Bodó, Eniko ^a   Tobin, Desmond J ^d   Kamenisch, York ^b   Bíró, Tamás ^e   Berneburg, Mark ^b   Funk, Wolfgang ^c   Paus, Ralf ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Klinik Dr Kozlowski   (Germany)

^d UNIVERSITY OF BRADFORD   (United Kingdom)

^e UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; FIBROBLAST GROWTH FACTOR 18; INTERLEUKIN 8; KERATINOCYTE GROWTH FACTOR; MELANIN; MITOCHONDRIAL DNA; PROTEIN P53;

ALOPECIA; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL PROLIFERATION; FEMALE; HAIR FOLLICLE; HAIR GROWTH; HUMAN; HUMAN TISSUE; KERATINOCYTE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 35348890110     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.061164     Document Type: Article

References (92)

1. Hesketh PJ, Batchelor D, Golant M, Lyman GH, Rhodes N, Yardley D: Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches. Support Care Cancer 2004, 12:543-549
2. Fraiser LH, Kanekal S, Kehrer JP: Cyclophosphamide toxicity. Characterising and avoiding the problem. Drugs 1991, 42:781-795
3. Wang J, Lu Z, Au JL: Protection against chemotherapy-induced alopecia. Pharm Res 2006, 23:2505-2514
4. Merk HF: Drugs affecting hair growth. Biology of the skin and hair growth. Edited by AG Lyne, BF Short. Sydney, Augus and Robertson, 1965, pp 601-609
5. Crounse GR, van Scott EJ: Changes in scalp hair roots as a measure of toxicity from cancer chemotherapeutic drugs. J Invest Dermatol 1960, 35:83-90
6. Braun-Falco O: Klinik und pathomechanismus der endoxan-alopecie als beitrag zum wesen cytostatischer alopecien. German. Arch Klin Exp Dermatol 1961, 212:194-216
7. Whiting D: Histopathology of alopecia areata, a new look. Arch Dermatol 2003, 139:1555-1559
8. Calabresi M, Anerein PC, Drucker BJ, Michaelson MD, Mitsiades CS, Gros PE, Ryan DP, Ramachandra S, Richardson PG, Supko JG, Wilson WH: Chemotherapy of neoplastic diseases. Goodman and Gilman's The Pharmacological Basis of Therapeutics. Edited by E Brunton, JS Lazo, KL Parker. New York, McGraw-Hill Publishing Co., 2005, pp 1315-1403
9. Kostanecki W, Kwiatkowska E, Zborzil J: Hair melanogenesis in endoxan alopecia and its modification by corticosteroids. Arch Klin Exp Dermatol 1966, 226:13-20
10. Paus R: Therapeutic strategies for treating hair loss. Drug Discov Today Therap Strategies 2006, 3:101-110
11. Paus R, Handjiski B, Eichmuller S, Czarnetzki BM: Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone. Am J Pathol 1994, 144:719-734
12. Paus R, Schilli MB, Handjiski B, Menrad A, Henz BM, Plonka P: Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice. Cancer Res 1996, 56:4438-4443
13. Maurer M, Handjiski B, Paus R: Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. Am J Pathol 1997, 150:1433-1441
14. Ohnemus U, Unalan M, Handjiski B, Paus R: Topical estrogen accelerates hair regrowth in mice after chemotherapy-induced alopecia by favoring the dystrophic catagen response pathway to damage. J Invest Dermatol 2004, 122:7-13
15. Lindner G, Botchkarev VA, Botchkareva NV, Ling G, van der Veen C, Paus R: Analysis of apoptpsis during hair follicle regression (catagen). Am J Pathol 1997, 151:1601-1617
16. Tobin DJ, Hagen E, Botchkarev VA, Paus R: Do hair bulb melanocytes undergo apoptosis during hair follicle regression (catagen)? J Invest Dermatol 1998, 111:941-947
17. Botchkarev VA, Komarova EA, Siebenhaar F, Botchkareva NV, Komarov PG, Maurer M, Gilchrest BA, Gudkov AV: p53 is essential for chemotherapy-induced hair loss. Cancer Res 2000, 60:5002-5006
18. Sharov AA, Li GZ, Palkina TN, Sharova TY, Gilchrest BA, Botchkarev VA: Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss. J Invest Dermatol 2003, 120:27-35
19. Botchkarev VA: Molecular mechanisms of chemotherapy-induced hair loss. J Investig Dermatol Symp Proc 2003, 8:72-75
20. Hussein AM, Jimenez JJ, McCall CA, Yunis AA: Protection from chemotherapy-induced alopecia in a rat model. Science 1990, 249:1564-1566
21. Jimenez JJ, Yunis AA: Protection from chemotherapy-induced alopecia by 1,25-dihydroxyvitamin D3. Cancer Res 1992, 52:5123-5125
22. Philpott MP, Green MR, Kealey T: Human hair growth in vitro. J Cell Sci 1990, 97:463-471
23. Hendrix S, Handjiski B, Peters EM, Paus R: A guide to assessing damage response pathways of the hair follicle: lessons from cyclophosphamide-induced alopecia in mice. J Invest Dermatol 2005, 125:42-51
24. Arnold H, Bourseaux F, Brock N: Chemotherapeutic action of a cyclic nitrogen mustard phosphamide ester (B 518-ASTA) in experimental tumours of the rat. Nature 1958, 181:931
25. Colvin OM: An overview of cyclophosphamide development and clinical applications. Curr Pharm Des 1999, 5:555-560
26. Connors TA, Cox PJ, Farmer PB, Foster AB, Jarman M: Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide. Biochem Pharmacol 1974, 23:115-129
27. Flowers J, Ludeman SM, Gamcsik MP, Colvin OM, Shao KL, Boal JH, Springer JB, Adams DJ: Evidence for a role of chloroethylaziridine in the cytotoxicity of cyclophosphamide. Cancer Chemother Pharmacol 2000, 45:335-344
28. Kehrer JP, Biswal SS: The molecular effects of acrolein. Toxicol Sci 2000, 57:6-15
29. Desmeules P, Devine PJ: Characterizing the ovotoxicity of cyclophosphamide metabolites on cultured mouse ovaries. Toxicol Sci 2006, 90:500-509
30. Orfanos CE, Gerstein E, Runne U: [Cytostatic hair loss as biological model. Cytostatic effect on healthy body cells.] German. Dtsch Med Wochenschr 1976, 101:1466-1468
31. Goldberg MT, Tackaberry LE, Hardy MH, Noseworthy JH: Nuclear aberrations in hair follicle cells of patients receiving cyclophosphamide. A possible in vivo assay for human exposure to genotoxic agents. Arch Toxicol 1990, 64:116-121
32. Slominski A, Tobin DJ, Shibahara S, Wortsman J: Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 2004, 84:1155-1228
33. Slominski A, Wortsman J, Plonka PM, Schallreuter KU, Paus R, Tobin DJ: Hair follicle pigmentation. J Invest Dermatol 2005, 124:13-21
34. Slominski A, Paus R: Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J Invest Dermatol 1993, 101:90S-97S
35. Slominski A, Paus R, Plonka P, Handjiski B, Maurer M, Chakraborty A, Mihm MC Jr: Pharmacological disruption of hair follicle pigmentation by cyclophosphamide as a model for studying the melanocyte response to and recovery from cytotoxic drug damage in situ. J Invest Dermatol 1996, 106:1203-1211
36. Tobin DJ, Slominski A, Botchkarev V, Paus R: The fate of hair follicle melanocytes during the hair growth cycle, J Investig Dermatol Symp Proc 1999, 4:323-332
37. Sharov AA, Siebenhaar F, Sharova TY, Botchkareva NV, Gilchrest BA, Botchkarev VA: Fas signaling is involved in the control of hair follicle response to chemotherapy. Cancer Res 2004, 64:6266-6270
38. Koch H, Wittern KP, Bergemann J: In human keratinocytes the common deletion reflects donor variabilities rather than chronologic aging and can be induced by ultraviolet A irradiation. J Invest Dermatol 2001, 117:892-897
39. Sung JS, Demple B: Roles of base excision repair subpathways in correcting oxidized abasic sites in DNA. FEBS J 2006, 273:1620-1629
40. Xu YJ, Kim EY, Demple B: Excision of C-4′-oxidized deoxyribose lesions from double-stranded DNA by human apurinic/apyrimidinic endonuclease (Ape1 protein) and DNA polymerase beta. J Biol Chem 1998, 273:28837-28844
41. Danilenko DM, Ring BD, Yanagihara D, Benson W, Wiemann B, Starnes CO, Pierce GF: Keratinocyte growth factor is an important endogenous mediator of hair follicle growth, development, and differentiation. Normalization of the nu/nu follicular differentiation defect and amelioration of chemotherapy-induced alopecia. Am J Pathol 1995, 147:145-154
42. Werner S: Keratinocyte growth factor: a unique player in epithelial repair processes. Cytokine Growth Factor Rev 1998, 9:153-165
43. Finch PW, Rubin JS: Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair. Adv Cancer Res 2004, 91:69-136
44. Braun S, Krampert M, Bodo E, Born-Berclaz C, Paus R, Werner S: Keratinocyte growth factor protects epidermis and hair follicles from cell death induced by UV irradiation, chemotherapeutic or cytotoxic agents. J Cell Sci 2006, 119:4841-4849
45. Anderson LW, Ludeman SM, Colvin OM, Grochow LB, Strong JM: Quantitation of 4-hydroxycyclophosphamide/aldophosphamide in whole blood. J Chromatogr B Biomed Appl 1995, 667:247-257
46. Anderson LW, Chen TL, Colvin OM, Grochow LB, Collins JM, Kennedy MJ, Strong JM: Cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy. Clin Cancer Res 1996, 2:1481-1487
47. Chen TL, Kennedy MJ, Anderson LW, Kiraly SB, Black KC, Colvin OM, Grochow LB: Nonlinear pharmacokinetics of cyclophosphamide and 4- hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation. Drug Metab Dispos 1997, 25:544-551
48. Magerl M, Paus R, Farjo N, Muller-Rover S, Peters EM, Foitzik K, Tobin DJ: Limitations of human occipital scalp hair follicle organ culture for studying the effects of minoxidil as a hair growth enhancer. Exp Dermatol 2004, 13:635-642
49. Bodo E, Biro T, Telek A, Czifra G, Griger Z, Toth BI, Mescalchin A, Ito T, Bettermann A, Kovács L, Paus R: A hot new twist to hair biology: involvement of vanilloid receptor-1 (VR1/TRPV1) signaling in human hair growth control. Am J Pathol 2005, 166:985-998
50. Randall VA, Sundberg JP, Philpott MP: Animal and in vitro models for the study of hair follicles. J Investig Dermatol Symp Proc 2003, 8:39-45
51. Kwon OS, Oh JK, Kim MH, Park SH, Pyo HK, Kim KH, Cho KH, Eun HC: Human hair growth ex vivo is correlated with in vivo hair growth: selective categorization of hair follicles for more reliable hair follicle organ culture. Arch Dermatol Res 2006, 297:367-371
52. Stenn KS, Paus R: Controls of hair follicle cycling. Physiol Rev 2001, 81:449-494
53. Kligman AM: The human hair cycle. J Invest Dermatol 1959, 33:307-316
54. Tobin DJ, Mandir N, Dover R: Morphological analysis of in vitro human hair growth. Arch Dermatol Res 1993, 285:158-164
55. Barbosa AJ, Castro LP, Margarida A, Nogueira MF: A simple and economical modification of the Masson-Fontana method for staining melanin granules and enterochromaffin cells. Stain Technol 1984, 59:193-196
56. Murata M, Suzuki T, Midorikawa K, Oikawa S, Kawanishi S: Oxidative DNA damage induced by a hydroperoxide derivative of cyclophosphamide. Free Radic Biol Med 2004, 37:793-802
57. Toyokuni S, Tanaka T, Hattori Y, Nishiyama Y, Yoshida A, Uchida K, Hiai H, Ochi H, Osawa T: Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 1997, 76:365-374
58. Berneburg M, Kamenisch Y, Krutmann J, Rocken M: To repair or not to repair - no longer a question: repair of mitochondrial DNA shielding against age and cancer. Exp Dermatol 2006, 15:1005-1015
59. Lu Z, Hasse S, Bodo E, Rose C, Funk W, Paus R: Towards the development of a simplified long-term organ culture method for human scalp skin and its appendages under serum-free conditions. Exp Dermatol 2007, 16:37-44
60. Beattie PE, Finlan LE, Kernohan NM, Thomson G, Hupp TR, Ibbotson SH: The effect of ultraviolet (UV) A1, UVB and solar-simulated radiation on p53 activation and p21. Br J Dermatol 2005, 152:1001-1008
61. Berneburg M, Gremmel T, Kurten V, Schroeder P, Hertel I, von Mikecz A, Wild S, Chen M, Declercq L, Matsui M, Ruzicka T, Krutmann J: Creatine supplementation normalizes mutagenesis of mitochondrial DNA as well as functional consequences. J Invest Dermatol 2005, 125:213-220
62. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45
63. Müller-Röver S, Handjiski B, van der Veen C, Eichmuller S, Foitzik K, McKay IA, Stenn KS, Paus R: A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol 2001, 117:3-15
64. Peters EM, Hansen MG, Overall RW, Nakamura M, Pertile P, Klapp BF, Arck PC, Paus R: Control of human hair growth by neurotrophins: brain-derived neurotrophic factor inhibits hair shaft elongation, induces catagen, and stimulates follicular transforming growth factor beta2 expression. J Invest Dermatol 2005, 124:675-685
65. Paus R, Foitzik K: In search of the "hair cycle clock": a guided tour. Differentiation 2004, 72:489-511
66. Tobin DJ, Foitzik K, Reinheckel T, Mecklenburg L, Botchkarev VA, Peters C, Paus R: The lysosomal protease cathepsin L is an important regulator of keratinocyte and melanocyte differentiation during hair follicle morphogenesis and cycling. Am J Pathol 2002, 160:1807-1821
67. Morioka K: Hair Follicle, Differentiation under the Electron Microscope. Tokyo, Springer, 2004
68. Vojtesek B, Bartek J, Midgley CA, Lane DP: An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 1992, 151:237-244
69. Berneburg M, Grether-Beck S, Kurten V, Ruzicka T, Briviba K, Sies H, Krutmann J: Singlet oxygen mediates the UVA-induced generation of the photoaging-associated mitochondrial common deletion. J Biol Chem 1999, 274:15345-15349
70. Berneburg M, Plettenberg H, Medve-Konig K, Pfahlberg A, Gers-Barlag H, Gefeller O, Krutmann J: Induction of the photoaging-associated mitochondrial common deletion in vivo in normal human skin. J Invest Dermatol 2004, 122:1277-1283
71. Zaun H: Experimental studies on the pathogenesis of "mixed alopecia" in animals. Arch Klin Exp Dermatol 1964, 221:75-84
72. Dong Q, Barsky D, Colvin ME, Melius CF, Ludeman SM, Moravek JF, Colvin OM, Bigner DD, Modrich P, Friedman HS: A structural basis for a phosphoramide mustard-induced DNA interstrand cross-link at 5′-d(GAC). Proc Natl Acad Sci USA 1995, 92:12170-12174
73. Paus R, Cotsarelis G: The biology of hair follicles. N Engl J Med 1999, 341:491-497
74. Kern JC, Kehrer JP: Acrolein-induced cell death: a caspase-influenced decision between apoptosis and oncosis/necrosis. Chem Biol Interact 2002, 139:79-95
75. Liu-Snyder P, McNally H, Shi R, Borgens RB: Acrolein-mediated mechanisms of neuronal death. J Neurosci Res 2006, 84:209-218
76. Koppel RA, Boh EE: Cutaneous reactions to chemotherapeutic agents. Am J Med Sci 2001, 321:327-335
77. de Jonge ME, Mathot RA, Dalesio O, Huitema AD, Rodenhuis S, Beijnen JH: Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy. Bone Marrow Transplant 2002, 30:593-597
78. Souid AK, Tacka KA, Galvan KA, Penefsky HS: Immediate effects of anticancer drugs on mitochondrial oxygen consumption. Biochem Pharmacol 2003, 66:977-987
79. Tacka KA, Dabrowiak JC, Goodisman J, Souid AK: Kinetic analysis of the reactions of 4-hydroperoxycyclophosphamide and acrolein with glutathione, mesna, and WR-1065, Drug Metab Dispos 2002, 30:875-882
80. Jia L, Liu Z, Sun L, Miller SS, Ames BN, Cotman CW, Liu J: Acrolein, a toxicant in cigarette smoke, causes oxidative damage and mitochondrial dysfunction in RPE cells: protection by (R)-α-lipoic acid. Invest Ophthalmol Vis Sci 2007, 48:339-348
81. Eicker J, Kurten V, Wild S, Riss G, Goralozyk R, Krutmann J, Berneburg M: Betacarotene supplementation protects from photoaging-associated mitochondrial DNA mutation. Photochem Photobiol Sci 2003, 2:655-659
82. Fischer TW, Sweatman TW, Semak I, Sayre RM, Wortsman J, Slominski A: Constitutive and UV-induced metabolism of melatonin in keratinocytes and cell-free systems. FASEB J 2006, 20:1564-1566
83. Lademann J, Otberg N, Jacobi U, Hoffman RM, Blume-Peytavi U: Follicular penetration and targeting. J Investig Dermatol Symp Proc 2005, 10:301-303
84. Hoffman RM: Topical liposome targeting of dyes, melanins, genes, and proteins selectively to hair follicles. J Drug Target 1998, 5:67-74
85. Li L, Hoffman RM: Topical liposome delivery of molecules to hair follicles in mice. J Dermatol Sci 1997, 14:101-108
86. Domashenko A, Gupta S, Cotsarelis G: Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex. Nat Biotechnol 2000, 18:420-423
87. Kawano M, Komi-Kuramochi A, Asada M, Suzuki M, Oki J, Jiang J, Imamura T: Comprehensive analysis of FGF and FGFR expression in skin: FGF18 is highly expressed in hair follicles and capable of inducing anagen from telogen stage hair follicles. J Invest Dermatol 2005, 124:877-885
88. Ohyama M, Terunuma A, Tock CL, Radonovich MF, Pise-Masison CA, Hopping SB, Brady JN, Udey MC, Vogel JC: Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest 2006, 116:249-260
89. Kolehmainen J, Black GC, Saarinen A, Chandler K, Clayton-Smith J, Traskelin AL, Perveen R, Kivitie-Kallio S, Norio R, Warburg M, Fryns JP, de la Chapelle A, Lehesjoki AE: Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport. Am J Hum Genet 2003, 72:1359-1369
90. Hashimoto T, Kazama T, Ito M, Urano K, Katakai Y, Yamaguchi N, Ueyama Y: Histologic and cell kinetic studies of hair loss and subsequent recovery process of human scalp hair follicles grafted onto severe combined immunodeficient mice. J Invest Dermatol 2000, 115:200-206
91. Botchkarev V, Sharov AA, Syska W, Maurer M, Gilchrest BA: Involvement of p53 and Fas in hair follicle apoptosis in human skin/SCID model for chemotherapy-induced hair loss. J Invest Dermatol 2002, 119:286
92. Ohnemus U, Uenalan M, Inzunza J, Gustafsson JA, Paus R: The hair follicle as an estrogen target and source. Endocr Rev 2006, 27:677-706